Diagnostic information services provider Quest Diagnostics (NYSE:DGX) confirmed on Monday that it has completed its acquisition of selected laboratory assets from OhioHealth, a not-for-profit, charitable, integrated health system.
This acquisition aims to broaden access to cost-effective and innovative laboratory services in Ohio.
Quest's full-service laboratory in Pittsburgh will provide most of the outreach testing previously performed by OhioHealth. OhioHealth will continue to own and operate its hospital labs for inpatient and hospital-based outpatient care as well as anatomic pathology and oncology services.
Financial details of the acquisition were not disclosed.
GSK PLC announces acceptance of NDA for gepotidacin by US FDA
Anixa Biosciences administers second dose of CAR-T therapy to individual patient
RevOpsis Therapeutics receives SBIR grant of over USD1.8m
AtomVie Global Radiopharma partners with Radiopharm Ventures
Lipella granted patent for innovative drug delivery technology
Adocia patents stable hormone combinations for obesity and diabetes
Accord BioPharma's IMULDOSA receives US FDA approval to treat chronic inflammatory conditions
RedHill Biopharma's opaganib selected for Ebola treatment development by BARDA
Quest Diagnostics acquires OhioHealth lab assets
Exelixis and Merck collaborate on clinical development of zanzalintinib
BD launches automated reagent kit to streamline single-cell discovery studies
Transgene's Phase II trial of TG4001 falls short of primary objective
GSK reports positive Phase III results for depemokimab in chronic rhinosinusitis with nasal polyps
SkylineDx reveals new data from the MERLIN_001 prospective US multi-centre trial